We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asarfi Hospital Limited has filed a compliance statement confirming that there was no material deviation in the utilisation of IPO proceeds for the year ended March 31, 2026. The company had raised Rs. 26.94 crore through an IPO of 51,80,000 equity shares allotted on July 26, 2023. The funds were deployed as per the original objects: Rs. 12.22 crore towards part funding of capital expenditure for a Cancer Hospital at Ranguni, Jharkhand; Rs. 7.65 crore for acquiring land on leasehold basis for a Health Management and Research Institute at Ranchi; Rs. 3.83 crore for issue-related expenses; and Rs. 3.23 crore for general corporate purposes. Both the Audit Committee and auditors have stated no comments on the utilisation.
This is a routine regulatory compliance filing with no material impact on shareholders. The absence of any deviation indicates the company is deploying IPO funds as promised in its offer document, which is a positive sign for investor confidence.